Catalyst Wire Dossier Catalyst Wire Dossier

BRINEURA

cerliponase alfa · BioMarin Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for BRINEURA, covering 2017-04-27 to 2026-06-11. Get the full timeline:

Most recent: EMA Authorised: Brineura (cerliponase alfa) — BioMarin International Limited

See pricing